Read our key points summary of a recent IMS presentation to learn more about novel bispecific antibodies linvoseltamab, ABBV-383, alnuctamab, and cevostamab!

loom.ly/spWk6NE
#mmsm #myeloma #bispecifics

Could modality and administration route of BCMA-directed immunotherapies impact incidence and rate of CRS in patients with relapsed/refractory #MultipleMyeloma ?

Read our article to learn the latest data!
loom.ly/xUEI2us
#mmsm #myeloma #CRS

Could dual antigen targeting help overcome resistance mechanisms to immune therapies in #MultipleMyeloma ?

Read our latest article to learn the rationale and preclinical evidence!
loom.ly/GMA4hjg
#mmsm #myeloma

🎥 The Multiple Myeloma Hub was pleased to speak to Irene Ghobrial, Dana-Farber, Boston, US.

We asked, What is the rationale for T-cell therapies in the treatment of smoldering MM?

Watch here: loom.ly/R8uhIHw
#mmsm #myeloma

🚨 NEWS 🚨

European Commission approves cilta-cel for the treatment of relapsed/refractory #MultipleMyeloma after ≥1 prior therapy, including an IMiD or PI, who are lenalidomide-refractory with disease progression on the last therapy.

Read more: loom.ly/sDuKN_s
#Myeloma

Check out our latest article to learn about the mechanism of antigen escape and acquired resistance to T-cell-directed therapies!

loom.ly/ut_XlxQ
#mmsm #myeloma

Enhance your understanding of T-cell engagers and their mechanism of action by catching up with the #MultipleMyeloma Hub’s recent symposium, which examined current and future perspectives for #bispecific antibodies.

Watch Sagar Lonial MD's talk here 👇
loom.ly/uibXwK4

🎥 The Lymphoma Hub and Multiple Myeloma Hub were pleased to speak to Anna Sureda.

We asked, What is the rationale for monitoring secondary malignancies after BCMA and CD19 CAR T-cell therapy?

Watch here: loom.ly/hjUx93Y
#mmsm #myeloma #lymphoma #lymsm

🎥 The Multiple Myeloma Hub and @LymphomaHub were pleased to speak to Anna Sureda.

We asked, What is the rationale for monitoring secondary malignancies after BCMA and CD19 CAR T-cell therapy?
Watch here: loom.ly/UKDHFHI
#mmsm #myeloma